In this study, we aimed to evaluate the immunohistochemical expression of stem cell marker LGR5 and its co-expression with Β-catenin in sporadic colorectal carcinoma versus adenomas and to assess the correlation of their expression with the clinicopathological characters. The gene discussed is LGR5; the disease is adenoma.